Finanzwire Finanzwire
Basculer en Français
11218 Companies
248777 Keywords
176570 Articles
134620 Press releases
Headlines Articles Press releases Rakovina Therapeutics Inc. Remove
  1. Home
  2. Companies
  3. Rakovina Therapeutics Inc.
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 09/02/2026 at 18:53, 1 month 20 days ago

    Rakovina Therapeutics Inc. Receives Downgrade from First Berlin Equity Research

    Licensing Deal Price Target Revision Rakovina Therapeutics AI-powered Pipeline Kt-5000 Program
  • PRESS RELEASE

    published on 09/02/2026 at 18:48, 1 month 20 days ago

    Original-Research: Rakovina Therapeutics Inc. (von First Berlin Equity Research GmbH): Add

    First Berlin Equity Research downgrades Rakovina Therapeutics Inc. to ADD and lowers price target to CAD 0.25 in latest research update
    First Berlin Equity Research Research Update Price Target Rakovina Therapeutics Inc. Stock Downgrade
    Logo of Rakovina Therapeutics Inc.
  • BRIEF

    published on 04/02/2025 at 15:36, 1 year 6 months ago

    Rakovina Therapeutics Receives Buy Rating from First Berlin Equity Research

    Artificial Intelligence DNA Damage Response Rakovina Therapeutics PARP And ATR Biotech Investment
  • PRESS RELEASE

    published on 04/02/2025 at 15:31, 1 year 6 months ago

    Original-Research: Rakovina Therapeutics Inc. (von First Berlin Equity Research GmbH): Buy

    First Berlin Equity Research initiates coverage on Rakovina Therapeutics Inc. with a Buy recommendation and CAD 0.40 target price. Rakovina focuses on DNA Damage Response pathways in developing next-gen cancer treatments
    First Berlin Equity Research Buy Recommendation Rakovina Therapeutics Inc. DNA Damage Response Pathways CAD 0.40 Target Price
    Logo of Rakovina Therapeutics Inc.
Accesswire
  • Published on 10/23/2026 at 02:20, 7 hours 35 minutes ago

    Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering

  • Published on 10/22/2026 at 23:30, 10 hours 25 minutes ago

    Cypher Announces Subscription Receipt Offering

  • Published on 10/22/2026 at 22:30, 11 hours 25 minutes ago

    Unusual Machines to Announce Third Quarter 2026 Financial Results and Provide Corporate Update

  • Published on 10/22/2026 at 16:00, 17 hours 55 minutes ago

    Future Fuels Announces Closing of Brokered Offering for Gross Proceeds of C$6.6 Million

  • Published on 10/22/2026 at 14:30, 19 hours 25 minutes ago

    Unusual Machines Receives $16.9 Million Purchase Order from Powerus for American-Made Drone Components

View all ACCESSWIRE
EQS Group
  • Published on 10/23/2026 at 09:00, 55 minutes ago

    Municipality Finance issues a USD 135 million tap under its MTN programme

  • Published on 10/23/2026 at 09:00, 55 minutes ago

    Original-Research: THE NAGA GROUP AG (von NuWays AG): BUY

  • Published on 10/23/2026 at 09:00, 55 minutes ago

    Official List Notice

  • Published on 10/23/2026 at 08:00, 1 hour 55 minutes ago

    Cairn Homes Plc: Transaction in Own Shares

  • Published on 10/23/2026 at 07:00, 2 hours 55 minutes ago

    EQS-Adhoc: BB Biotech AG publishes its interim report

View all EQS
Les Echos
  • Published on 10/23/2026 at 07:00, 2 hours 55 minutes ago

    Safran reports third quarter 2026 revenue

  • Published on 10/22/2026 at 18:00, 15 hours 55 minutes ago

    THERMADOR GROUPE : Completion of the share buy-back programme launched in August

  • Published on 10/22/2026 at 18:00, 15 hours 55 minutes ago

    bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics

  • Published on 10/22/2026 at 18:00, 15 hours 55 minutes ago

    H1 2026: marked improvement in operating results

  • Published on 10/22/2026 at 17:47, 16 hours 8 minutes ago

    Aéroports de Paris SA - 2026 9-month revenue

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy